Targeting WNT/β-Catenin via Modulating EZH2 Function: A New Chapter in the Treatment of β-Catenin Mutant Hepatocellular Carcinoma?

被引:1
|
作者
Hung, Man Hsin [1 ]
Wang, Xin Wei [1 ,2 ,3 ,4 ]
机构
[1] NCI, Ctr Canc Res, Lab Human Carcinogenesis, Bethesda, MD USA
[2] NCI, Ctr Canc Res, Liver Canc Program, Bethesda, MD USA
[3] NCI, Lab Human Carcinogenesis, Bethesda, MD 20892 USA
[4] NCI, Liver Canc Program, Bethesda, MD 20892 USA
关键词
MICE;
D O I
10.1158/0008-5472.CAN-23-2921
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a recent study, Rialdi and colleagues identified a specific vulnerability in beta-catenin mutant hepatocellular carcinoma (HCC) via EZH2-mediated suppression of WNT signaling and revealed the selective anti-HCC activity of WNTinib, a chemical derivative of regorafenib and sorafenib in targeting this vulnerability. Their discoveries highlight the role of EZH2 in modulating WNT signaling and suggest an implication of WNTinihb as a small-molecule inhibitor for the treatment of HCC with activated WNT/beta-catenin.
引用
收藏
页码:3498 / 3500
页数:3
相关论文
共 50 条
  • [41] MiR-214 Regulates the Human Hair Follicle Stem Cell Proliferation and Differentiation by Targeting EZH2 and Wnt/β-Catenin Signaling Way In Vitro
    Ke-Tao Du
    Jia-Qin Deng
    Xu-Guang He
    Zhao-ping Liu
    Cheng Peng
    Ming-Sheng Zhang
    Tissue Engineering and Regenerative Medicine, 2018, 15 : 341 - 350
  • [42] MiR-214 Regulates the Human Hair Follicle Stem Cell Proliferation and Differentiation by Targeting EZH2 and Wnt/β-Catenin Signaling Way In Vitro
    Du, Ke-Tao
    Deng, Jia-Qin
    He, Xu-Guang
    Liu, Zhao-ping
    Peng, Cheng
    Zhang, Ming-Sheng
    TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2018, 15 (03) : 341 - 350
  • [43] ATDC promotes the growth and invasion of hepatocellular carcinoma cells by modulating GSK-3β/Wnt/β-catenin signalling
    Li, Weizhi
    Xue, Hui
    Li, Yingchao
    Li, Peijie
    Ma, Fuquan
    Liu, Mengying
    Kong, Shuzhen
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2019, 46 (09) : 845 - 853
  • [44] TLK2 promotes progression of hepatocellular carcinoma through Wnt/β-catenin signaling
    He, Ting
    Xu, Borui
    Ma, Haiqing
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (07)
  • [45] SENP2 Regulates Hepatocellular Carcinoma Cell Growth by Modulating the Stability of β-catenin
    Shen, Huo-Jian
    Zhu, Hong-Yi
    Yang, Chao
    Ji, Fu
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) : 3583 - 3587
  • [46] Tiam1 promotes thyroid carcinoma metastasis by modulating EMT via Wnt/β-catenin signaling
    Liu, Lin
    Wu, Bo
    Cai, Haidong
    Li, Dan
    Ma, Yushui
    Zhu, Xuchao
    Lv, Zhongwei
    Fan, Youben
    Zhang, Xiaoping
    EXPERIMENTAL CELL RESEARCH, 2018, 362 (02) : 532 - 540
  • [47] SULF2 Promotes Tumorigenesis of Hepatocellular Carcinoma By Activating the Wnt/β-Catenin Pathway
    Lai, Jinping
    Yu, Chunrong
    Moser, Catherine D.
    Isomoto, Hajime
    Lee, Ju-Seog
    Adjei, Alex A.
    Thorgeirsson, Snorri
    Sanderson, Schuyler
    Roberts, Lewis R.
    GASTROENTEROLOGY, 2009, 136 (05) : A793 - A793
  • [48] MiR-137 regulates the proliferation and invasion of glioma cells through EZH2/Wnt/β-catenin signaling pathway
    Wang, Zong
    Yuan, Jiangwei
    Yang, Yang
    Li, Li
    Liu, Jidong
    Wang, Ying
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (01): : 385 - 392
  • [49] miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway
    Cao, Fei
    Yin, Li-Xue
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2019, 106 : 34 - 43
  • [50] miR-550a-5p promotes the proliferation and migration of hepatocellular carcinoma by targeting GNE via the Wnt/?-catenin signaling pathway
    Li, Chun -Ming
    Wu, Wu
    Zhu, Zhu
    Lu, Pei-Lin
    Gong, Jian-Ping
    Ma, Rong
    NEOPLASMA, 2022, 69 (06) : 1359 - 1372